| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $57.72 | 03 Mar 2026 | Direct |
| RAPT Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 0 | 03 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | 03 Mar 2026 | 2 | $0 | 4 | Director | 05 Mar 2026, 08:59 |
| RAPT | RAPT Therapeutics, Inc. | 30 Jan 2026 | 1 | $0 | 4 | Director | 02 Feb 2026, 17:38 |
| RAPT | RAPT Therapeutics, Inc. | 21 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 20:43 |
| RAPT | RAPT Therapeutics, Inc. | 21 Jun 2025 | 0 | $0 | 3 | Director | 30 Jun 2025, 20:41 |